| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJME048061 |
| P698 | PubMed publication ID | 15007111 |
| P50 | author | Eric J. Topol | Q5387640 |
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circulatory system | Q11068 |
| statin therapy | Q62562875 | ||
| P304 | page(s) | 1562-1564 | |
| P577 | publication date | 2004-03-08 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Intensive statin therapy--a sea change in cardiovascular prevention | |
| P478 | volume | 350 |
| Q47136902 | 'Me-Too' Innovation in Pharmaceutical Markets |
| Q57841283 | A Rare Case of Acute Pancreatitis Due to Very Severe Hypertriglyceridemia (>10 000 mg/dL) Successfully Resolved With Insulin Therapy Alone: A Case Report and Literature Review |
| Q44990024 | Aggressive lowering of low-density lipoprotein cholesterol: do the studies apply to the elderly? |
| Q24794337 | Assessing compliance of cardiologists with the national cholesterol education program (NCEP) III guidelines in an ambulatory care setting |
| Q35119935 | Atorvastatin inhibits inflammatory hypernociception. |
| Q30477204 | Brain cholesterol turnover required for geranylgeraniol production and learning in mice |
| Q28200344 | C-reactive protein (CRP)-lowering agents |
| Q37024373 | Can intensive statin therapy halt the progression of atherosclerosis? Recent evidence and potential implications for patient management |
| Q41289867 | Complex health problems and mortality among the oldest old in Sweden: decreased risk for men between 1992 and 2002. |
| Q37321653 | Dose-dependency in pleiotropic effects of atorvastatin |
| Q79186802 | Drug costs associated with non-adherence to cholesterol management guidelines for primary prevention of cardiovascular disease in an elderly population: the Rotterdam study |
| Q45925043 | Effects of simvastatin and carnitine versus simvastatin on lipoprotein(a) and apoprotein(a) in type 2 diabetes mellitus. |
| Q38106998 | Emerging anti-inflammatory drugs for atherosclerosis |
| Q37070772 | Evolution of anticoagulant and antiplatelet therapy: benefits and risks of contemporary pharmacologic agents and their implications for myonecrosis and bleeding in percutaneous coronary intervention. |
| Q40431362 | From healthy survivors to sick survivors--implications for the twenty-first century. |
| Q38906383 | Genetic basis for developmental toxicity due to statin intake using embryonic stem cell differentiation model |
| Q46125723 | Hydroxypropylmethylcellulose lowers cholesterol in statin-treated men and women with primary hypercholesterolemia |
| Q35686315 | Hypertriglyceridemia-induced recurrent acute pancreatitis: A case-based review |
| Q24672914 | Hypertriglyceridemia: its etiology, effects and treatment |
| Q30586189 | Integrative analysis of proteomic and transcriptomic data for identification of pathways related to simvastatin-induced hepatotoxicity |
| Q36228304 | Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin |
| Q35882448 | Isoprenoids: remarkable diversity of form and function |
| Q24630160 | Jupiter to earth: a statin helps people with normal LDL-C and high hs-CRP, but what does it mean? |
| Q79233378 | Low-density lipoprotein cholesterol lowering in the prevention of CHD: how low should we go? |
| Q48743494 | Negative impact of statins on oligodendrocytes and myelin formation in vitro and in vivo. |
| Q48274225 | Neurocognitive performance after PCSK9 inhibitor therapy: Current state of the evidence |
| Q46522162 | New benefits of statin treatment |
| Q80407040 | Over-the-counter statins |
| Q24803635 | Plant sterols: factors affecting their efficacy and safety as functional food ingredients |
| Q36869615 | Prescription drug cost sharing: associations with medication and medical utilization and spending and health. |
| Q36390065 | Recent trends in coronary intravascular ultrasound: tracking atherosclerosis, pursuit of vulnerable plaques, and beyond |
| Q36752063 | Rosuvastatin: a highly potent statin for the prevention and management of coronary artery disease |
| Q34650855 | Simvastatin promotes Th2-type responses through the induction of the chitinase family member Ym1 in dendritic cells |
| Q44651861 | Statin therapy does not improve lung function in asthma: a meta-analysis of randomized controlled trials |
| Q36147416 | Statins and CVD prevention in the diabetic population: implications of the CARDS trial |
| Q36337970 | Statins and cancer prevention |
| Q81884102 | Statins and stroke prevention |
| Q37332635 | Statins inhibit the growth of variant human embryonic stem cells and cancer cells in vitro but not normal human embryonic stem cells |
| Q36085649 | Statins--a cure-all for the brain? |
| Q43190275 | The effect of statin therapy on allergic patients with asthma |
| Q35595431 | The many roles of statins in ischemic stroke |
| Q36176396 | The nurse practitioner's role in helping patients achieve lipid goals with statin therapy |
| Q38080920 | The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium |
| Q38262892 | Trends in the Use of Evidence-based Therapies Early in the Course of Acute Myocardial Infarction and its Influence on Short Term Patient Outcomes |
Search more.